Coronary Artery Disease Clinical Trial
Official title:
RESTenosis in Patients With Contact ALLergy to Metals Zabrze Study
In-stent restenosis remains one of the most challenging problems in patients after coronary artery angioplasty. Angiographically, it is discovered in 10% of the patients after drug-eluting stent (DES) implantation. There are multiple factors causing restenosis, which can be divided into two major groups: first vessel-dependent (based on the vessel's tortuosity, dimensions and lesion's calcification, all leading to suboptimal stent expansion), and second dependent on the inflammatory processes caused by the intervention. Study objectives is the analysis of the possible correlation between allergy to metals utilised during the stent manufacturing (nickel, cobalt, chromium, molybdenum, tungsten) and in-stent restenosis occurence. The angiographic results of stent implantation, and in-stent restenosis will be assessed independently by two skilled interventional cardiologists, and in case of their discrepant opinions, the decision will be made on the basis of the third cardiologist. The tests will be applicated during the hospitalisation, then read after 48 hours and 72 hours, and subsequently interpreted by the skilled dermatologist, during the hospital stay or afterwards.
Introduction:
In-stent restenosis remains one of the most challenging problems in patients after coronary
artery angioplasty. Angiographically, it is discovered in 10% of the patients after
drug-eluting stent (DES) implantation. There are multiple factors causing restenosis, which
can be divided into two major groups: first vessel-dependent (based on the vessel's
tortuosity, dimensions and lesion's calcification, all leading to suboptimal stent
expansion), and second dependent on the inflammatory processes caused by the intervention.
Although the proper stent expansion depends mostly on the cardiologist's manual dexterity,
the inflammation development does totally not depend on the operator. The allergic reactions
to metals are likely to be one of the underlying causes of inflammation. Among the most
prevalent allergens, cobalt, chromium, nickel, and tungsten used as the stent materials are
causing the most intensive contact allergic reaction. The allergic process induced by the
aforementioned metals belongs to type IV contact allergy (T-cell mediated). Stent
implantation results in life-long contact with metal, thus in allergic patients, it is likely
to develop local reactions leading to in-stent restenosis. Up to date, there have been
approximately one thousand in-stent restenosis cases documented in patients with confirmed
contact allergy to stent metals.
Study objectives:
Analysis of the possible correlation between allergy to metals utilised during the stent
manufacturing (nickel, cobalt, chromium, molybdenum, tungsten) and in-stent restenosis
occurence.
Materials and methods:
The study will consist of two arms:
First arm: Patch tests for the metals used in stent production will be applicated in the
patients with angiographically proven in-stent restenosis developed after technically correct
implantation.
Second arm: In patients with (technically correctly) implanted stent, patch tests will be
applicated to identify cases with contact allergy. The patients will then be monitored for a
6-12 months follow-up period in purpose of evaluating the dependance between in-stent
restenosis and contact allergy.
The angiographic results of stent implantation, and in-stent restenosis will be assessed
independently by two skilled interventional cardiologists, and in case of their discrepant
opinions, the decision will be made on the basis of the third cardiologist.
The tests will be applicated during the hospitalisation, then read after 48 hours and 72
hours, and subsequently interpreted by the skilled dermatologist, during the hospital stay or
afterwards.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |